| Ident. | Authors (with country if any) | Title |
|---|
| 000225 |
Peter A. Tass [Allemagne] ; LI QIN [République populaire de Chine, Royaume-Uni] ; Christian Hauptmann [Allemagne] ; Sandra Dovero [France] ; Erwan Bezard [République populaire de Chine, Royaume-Uni, France] ; Thomas Boraud [France] ; Wassilios G. Meissner [France] | Coordinated Reset Has Sustained Aftereffects in Parkinsonian Monkeys |
| 000244 |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale |
| 000295 |
Timothy P. Gilmour [États-Unis] ; Christopher A. Lieu [États-Unis] ; Mark J. Nolt [États-Unis] ; Brigitte Piallat [France] ; Milind Deogaonkar [États-Unis] ; Thyagarajan Subramanian [États-Unis] | The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys |
| 000346 |
Giselle Charron [France] ; Evelyne Doudnikoff [France] ; Alexis Laux [France] ; Amandine Berthet [France] ; Gregory Porras [France] ; Marie-Hélène Canron [France] ; Pedro Barroso-Chinea [France] ; QIN LI [République populaire de Chine] ; CHUAN QIN [République populaire de Chine] ; Marika Nosten-Bertrand [France] ; Bruno Giros [France] ; François Delalande [France] ; Alain Van Dorsselaer [France] ; Anne Vital [France] ; Yannick Goumon [France] ; Erwan Bezard [France, République populaire de Chine] | Endogenous morphine-like compound immunoreactivity increases in parkinsonism |
| 000619 |
Anne-Sophie Rolland [France] ; Dominique Tande [France] ; Maria-Trinidad Herrero [Espagne] ; Maria-Rosario Luquin [Espagne] ; Marianne Vazquez-Claverie [Espagne] ; Carine Karachi [France] ; Etienne C. Hirsch [France] ; Chantal Francois [France] | Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication |
| 000718 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000778 |
Ana Munoz [Suède] ; QIN LI [République populaire de Chine] ; Fabrizio Gardoni [Italie] ; Elena Marcello [Italie] ; CHUAN QIN [République populaire de Chine] ; Thomas Carlsson [Suède] ; Deniz Kirik [Suède] ; Monica Di Luca [Italie] ; Anders Björklund [Suède] ; Erwan Bezard [France] ; Manolo Carta [Suède] | Combined 5-HTjA and 5-HTjB receptor agonists for the treatment of L-DOPA-induced dyskinesia |
| 000856 |
Dieter Scheller [Allemagne] ; PIU CHAN [République populaire de Chine] ; QIN LI [Royaume-Uni] ; TAO WU [République populaire de Chine] ; RENLING ZHANG [République populaire de Chine] ; LE GUAN [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Celine Guigoni [France] ; Alan R. Crossman [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France] | Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease |
| 000919 |
Stéphanie Mounayar [France] ; Sabrina Boulet [France] ; Dominique Tande [France] ; Caroline Jan [France] ; Mathias Pessiglione [France] ; Etienne C. Hirsch [France] ; Jean Feger [France] ; Marc Savasta [France] ; Chantal Francois [France] ; Léon Tremblay [France] | A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery |
| 000990 |
Dominique Tande [France] ; Günter Höglinger [Allemagne] ; Thomas Debeir [France] ; Nils Freundlieb [Allemagne] ; Etienne C. Hirsch [France] ; Chantal Francois [France] | New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis |
| 000A35 |
Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada] | Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats |
| 000B46 |
I. J. Bohr [Royaume-Uni] ; M. A. Ray [Royaume-Uni] ; J. M. Mcintosh [États-Unis] ; S. Chalon [France] ; D. Guilloteau [France] ; I. G. Mckeith [Royaume-Uni] ; R. H. Perry [Royaume-Uni] ; F. Clementi [Italie] ; E. K. Perry [Royaume-Uni] ; J. A. Court [Royaume-Uni] ; M. A. Piggott [Royaume-Uni] | Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases : An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus |
| 000C46 |
Carlos Barcia [Espagne] ; Angel Sanchez Bahillo [Espagne] ; Emiliano Fernandez-Villalba [Espagne] ; Victor Bautista [Espagne] ; Maximo Poza Y. Poza [Espagne] ; Andrés Fernandez-Barreiro [Espagne] ; Etienne C. Hirsch [France] ; Maria-Trinidad Herrero [Espagne] | Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure |
| 000D54 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset |
| 000D74 |
Mathias Pessiglione [France] ; Dominique Guehl [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Feger [France] ; Léon Tremblay [France] | Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease |
| 000D92 |
L. Escola [France] ; Th. Michelet [France] ; F. Macia [France] ; D. Guehl [France] ; B. Bioulac [France] ; P. Burbaud [France] | Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: A clue to the pathophysiology of akinesia? |
| 000E10 |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys |
| 000E39 |
J. Feger [France] ; M. Pessigliore [France] ; C. Francois [France] ; L. Tremblay [France] ; E. Hirsch [France] | Modèles expérimentaux de la maladie de Parkinson |
| 000E92 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation |
| 000F12 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 000F24 |
Samuel G. Speciale [États-Unis] | MPTP: Insights into parkinsonian neurodegeneration |
| 000F42 |
J. S. Schneider [États-Unis] ; M. Giardiniere [États-Unis] ; P. Morain [France] | Effects of the prolyl endopeptidase inhibitor S17092 on cognitive deficits in chronic low dose MPTP-treated monkeys |
| 000F46 |
I. Ghorayeb [France] ; P. O. Fernagut [France] ; N. Stefanova [Autriche] ; G. K. Wenning [Autriche] ; B. Bioulac [France] ; F. Tison [France] | Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine + 3-nitropropionic acid model of striatonigral degeneration in monkeys |
| 000F53 |
Ludovic Escola [France] ; Thomas Michelet [France] ; Gaelle Douillard [France] ; Dominique Guehl [France] ; Bernard Bioulac [France] ; Pierre Burbaud [France] | Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys |
| 001038 |
E. Bezard [Royaume-Uni] ; T. Boraud [France] ; S. Chalon [France] ; J. M. Brotchie [Royaume-Uni] ; D. Guilloteau [France] ; C. E. Gross [France] | Pallidal border cells : An anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
| 001080 |
Thomas Boraud [France] ; Erwan Bezard [France] ; Bernard Bioulac [France] ; Christian E. Gross [France] | Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey |
| 001093 |
Thomas Poyot [France] ; Francoise Conde [France] ; Marie-Claude Gregoire [France] ; Vincent Frouin [France] ; Christine Coulon [France] ; Chantal Fuseau [France] ; Francoise Hinnen [France] ; Frédéric Dolle [France] ; Philippe Hantraye [France] ; Michel Bottlaender [France] | Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: Comparison with 6-[18f]Fluoro-L-Dopa |
| 001192 |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
| 001221 |
T. Boraud [France] ; E. Bezard [France] ; J. M. Stutzmann [France] ; B. Bioulac [France] ; C. E. Gross [France] | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey |
| 001327 |
J. H. Kordower [France] ; J. Bloch [Suisse] ; S. Y. Ma [France] ; YAPING CHU [France] ; S. Palfi [France] ; B. Z. Roitberg [France] ; M. Emborg [France] ; P. Hantraye [France] ; N. Deglon [Suisse] ; P. Aebischer [Suisse] | Lentiviral gene transfer to the nonhuman primate brain |
| 001336 |
H. Valette [France] ; M. Bottlaender [France] ; F. Dolle [France] ; I. Guenther [France] ; C. Fuseau [France] ; C. Coulon [France] ; M. Ottaviani [France] ; C. Crouzel [France] | Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380 |
| 001337 |
D. M. Gao [République populaire de Chine] ; A. Benazzouz [France] ; B. Piallat [France] ; K. Bressand [France] ; I. A. Ilinsky [États-Unis] ; K. Kultas-Ilinsky [République populaire de Chine] ; A. L. Benabid [France] | High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey |
| 001345 |
E. Bezard [France] ; C. Brefel [France] ; F. Tison [France] ; H. Peyro-Saint-Paul [France] ; P. Ladure [France] ; O. Rascol [France] ; C. E. Gross [France] | Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in mptp-treated monkey |
| 001409 |
J. Villares [France, Brésil] ; B. Faucheux [France] ; M. T. Herrero [Espagne] ; J. A. Obeso [Espagne] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys |
| 001414 |
E. Bezard [France] ; T. Boraud [France] ; C. Imbert [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Towards a dynamic approach of experimental parkinsonism |
| 001423 |
E. Bezard [France] ; J.-M. Stutzmann [France] ; C. Imbert [France] ; T. Boraud [France] ; A. Boireau [France] ; C. E. Gross [France] | Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model |
| 001425 |
H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël] | Physiology of MPTP tremor |
| 001446 |
E. Bezard [France] ; B. Bioulac [France] ; C. E. Gross [France] | Glutamatergic compensatory mechanisms in experimental parkinsonism |
| 001452 |
T. Boraud [France] ; E. Bezard [France] ; D. Guehl [France] ; B. Bioulac [France] ; C. Gross [France] | Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey |
| 001479 |
| ORGANISATION ANATOMIQUE ET FONCTIONNELLE DES GANGLIONS DE LA BASE DANS LES SYNDROMES PARKINSONIENS DU PRIMATE HUMAIN ET NON-HUMAIN |
| 001550 |
J. Yelnik [France] ; C. Francois [France] ; G. Percheron [France] | Spatial relationships between striatal axonal endings and pallidal neurons in macaque monkeys |
| 001554 |
R. Levy [France] ; L.-N. Hazrati [Canada] ; M.-T. Herrero [France, Espagne] ; M. Vila [France] ; O.-K. Hassani [France] ; M. Mouroux [France] ; M. Ruberg [France] ; H. Asensi [Espagne] ; Yves Agid [France] ; J. Feger [France] ; J. A. Obeso [Espagne] ; A. Parent [Canada] ; E. C. Hirsch [France] | Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states |
| 001558 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Presymptomatic revelation of experimental Parkinsonism |
| 001601 |
E. Bezard [France] ; C. Imbert [France] ; X. Deloire [France] ; B. Bioulac [France] ; C. E. Gross [France] | A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey |
| 001633 |
J. Guridi [Espagne] ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Yves Agid [France] ; E. Hirsch ; J. A. Obeso | Subthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis |
| 001644 |
M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. Hirsch | Metabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study |
| 001651 |
T. Boraud [France] ; E. Bezard [France] ; B. Bioulac [France] ; C. Gross [France] | High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey |
| 001654 |
M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni] | Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys |
| 001706 |
ABDELHAMID BENAZZOUZ [France] ; T. Boraud [France] ; P. Dubedat [France] ; A. Boireau [France] ; J.-M. Stutzmann [France] ; C. Gross [France] | Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey : a pilot study |
| 001729 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
| 001739 |
B. A. Faucheux [France] ; M. T. Herrero ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of[125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
| 001747 |
| Réalisation et caractérisation chez le babouin d'un modèle expérimental chronique de la maladie de Parkinson |
| 001808 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
| 001811 |
M. Varastet [France] ; D. Riche [France] ; M. Maziere [France] ; P. Hantraye [France] | Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease |
| 001861 |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France] | Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 001863 |
P. Gaspar [France] ; A. Febvret [France] ; J. Colombo | Serotonergic sprouting in primate MTP-induced hemiparkinsonism |
| 001878 |
M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France] | Gangliosides and parkinsonism |
| 001879 |
M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio | GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys |
| 001888 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ? |
| 001890 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 001953 |
A. Benazzouz [France] ; C. Gross ; J. Dupont [France] ; B. Bioulac | MPTP induced hemiparkinsonism in monkeys : behavioral, mechanographic, electromyographic and immunohistochemical studies |
| 001A11 |
M. Mavridis [France] ; A.-D. Degryse ; A. J. Lategan ; M. R. Marien ; F. C. Colpaert | Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tretrahydropyridine in monkeys : a possible role for the locus coeruleus in the progression of Parkinson's disease |
| 001B80 |
P. Hantraye ; B. Maziere ; M. Maziere ; H. Fukuda ; R. Naquet | Dopaminergic and benzodiazepine receptors studied in vivo by PET |
| 001B83 |
P. Hantraye ; C. Loc'H ; U. Tacke ; D. Riche ; O. Stulzaft ; D. Doudet ; B. Guibert ; R. Naquet ; B. Maziere ; M. Maziere | "In vivö visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates |
| 001B93 |
D. Doudet ; C. Gross ; P. Lebrun-Grandie ; B. Bioulac | MPTP primate model of Parkinson's disease: a mechanographic ansd electromyographic study |
